SARS-CoV2 disease seen through the prism of acutely decompensated chronic kidney disease and ischemic stroke: What lesson we have learned from using prophylaxis therapy of vascular thromboembolism?
SARS‐CoV2
acute kidney injury
chronic kidney disease
ischemic stroke
vascular thromboembolism anticoagulation
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
27
05
2020
revised:
29
08
2020
accepted:
01
09
2020
pubmed:
25
11
2020
medline:
25
11
2020
entrez:
24
11
2020
Statut:
epublish
Résumé
Our case underlines the tight management of antithrombotic therapy in the context of acutely decompensated chronic kidney disease, ischemic stroke, and SARS-CoV2 infection, the development of stroke as a SARS-CoV2 complication increase the chances of adverse outcomes that may be mitigated by a rapid recognition and institution of available treatments.
Identifiants
pubmed: 33230416
doi: 10.1002/ccr3.3385
pii: CCR33385
pmc: PMC7675693
doi:
Types de publication
Case Reports
Langues
eng
Pagination
3229-3233Informations de copyright
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
Authors declare no conflict of interest.